European Archives - Page 91 of 994 - European Medical Journal

Doctors in a surgery room standing in a line

Lord Darzi’s report on the NHS: What pharma needs to know

For the pharmaceutical industry, this situation highlights ways to step in as partners in healthcare innovation and support the NHS during a turbulent time.

New Guidelines for Metabolic Dysfunction-Associated Steatotic Liver Disease Management

The latest clinical guidelines for diagnosing and managing metabolic dysfunction-associated steatotic liver disease, previously known as NAFLD

The Androgen Deprivation Therapy Landscape in 2024 – Co-navigating the Available Options with Prostate Cancer Patients

The objectives of this symposium were to improve attendees’ knowledge on ADT, including the different therapeutic options available…

EMJ Urology 12 [Supplement 2] 2024

Explore the latest insights into the multifaceted aspects of prostate cancer (PCa) treatment presented at the 2024 European Association…

World Mental Health Day with Boehringer Ingelheim’s Nedim Pipic

Nedim Pipic, Senior Vice President and Global Therapeutic Area Head for Mental Health, Boehringer Ingelheim marks World Mental Health Day.

ESC 2024 Interview: Lis Neubeck

EMJ spoke to Lis Neubeck, Professor of Nursing and Head of Cardiovascular Health, Edinburgh Napier University, UK, at the European Society…

ESMO 2024 Interview: Jianjun Zhang

I think oncology has been at the bottom of my heart since I was in high school. When I was a young kid, my dream career was to become an…

US scientists win Nobel Prize for Medicine for discovering microRNA

American researchers Victor Ambros and Gary Ruvkun have been awarded the 2024 Nobel Prize in Physiology or Medicine for their pioneering discovery of microRNA.

Sudden Unexpected Infant Deaths Rose During the COVID-19 Pandemic

A study has revealed an increase in the rates of sudden unexpected infant death and sudden infant death syndrome during the COVID-19 pandemic compared to pre-pandemic levels.

PROMISE Criteria Accurately Predicts Survival in Prostate Cancer

Researchers have validated the prognostic value of PSMA-PET findings using PROMISE criteria to predict overall survival in prostate cancer patients